Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Therapeutic potential of PC-SOD evaluated preclinically

Dec. 5, 1997

OR-1384 at least equieffective to 5-ASA in acute and chronic colitis in mice

Dec. 5, 1997

HCV protease inhibitors to be designed and developed by BMS and Arris

Dec. 3, 1997

rhIL-10 improves quality of life in patients with Crohn's disease

Dec. 1, 1997

Rabeprazole safe and effective for short-term treatment of GERD

Nov. 28, 1997

Controlled trial of ofloxacin + IFN-alpha-2b in chronic hepatitis C

Nov. 27, 1997

Profile of hepatoprotective activity of picroliv in rats

Nov. 27, 1997

Fedotozine efficacy in functional dyspepsia established

Nov. 26, 1997

FR-127519: new CCK-A antagonist assessed in functional model

Nov. 25, 1997

NK3 antagonist demonstrates intestinal antiinflammatory activity

Nov. 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
Coreterra Therapeutics patents agents for schizophrenia
BioWorld Science
Work at Coreterra Therapeutics Inc. has led to the discovery of new thienyl compounds intended for potential use in the treatment of schizophrenia.